Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-21

Clinical Trial Update: Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis [Phase 3]

View source ↗

Summary

Phase 3 trial for TP-03 in treating Demodex blepharitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TP-03

Snippet

Sponsor: Tarsus Pharmaceuticals, Inc. | Conditions: Blepharitis | Phase 3 | Status: COMPLETED | Results posted: 2023-12-21